⌘K

Login Start Free

Home/Filings/4/0000899243-23-016709

4//SEC Filing

Bronstein Ben 4

Accession 0000899243-23-016709

CIK 0001341235other

View on SEC.gov Company Profile

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 4:23 PM ET

Size

7.0 KB

Accession

0000899243-23-016709

Insider Transaction Report

Form 4

Period: 2023-06-27

Aldeyra Therapeutics, Inc.ALDX

Director

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2023-06-27+9,604→ 0 total
Exercise: $0.55Exp: 2023-09-07→ Common Stock (9,604 underlying)
Exercise/Conversion
Common Stock
2023-06-27$0.55/sh+9,604$5,301→ 28,248 total

Footnotes (1)

[F1]The stock option is fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Aldeyra Therapeutics, Inc.

CIK 0001341235

Entity typeother

Related Parties

1

filerCIK 0001604458

Filing Metadata

Form type: 4
Filed: Jun 28, 8:00 PM ET
Accepted: Jun 29, 4:23 PM ET
Size: 7.0 KB

View on SEC.gov